Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.

Alkermes plc (Nasdaq: ALKS) today announced plans to present three posters related to ALKS 2680 at SLEEP 2024, the 38th ...

Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - - ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips As we delve deeper into 2024, biotech stocks are commanding the attention of ...

The company has put high expectations on the drug, an orexin-2 antagonist called seltorexant, as a cornerstone of its neuropsychiatry pipeline.

The singer-songwriter talks about the importance of having the language to express one's experiences to others. Marcus King on Battling Feelings of “Terrible Hopelessness” with Meaningful Communicatio ...

A new study reveals shared and distinct molecular changes in the brain and blood of individuals with PTSD and MDD.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Looking at individual holdings, Ensign Group Inc/the (ENSG) accounts for about 5.84% of total assets, followed by Organon & Co (OGN) and Alkermes Plc (ALKS). The top 10 holdings account for about ...

Markets News, May 9, 2024: Dow Finishes More Than 300 Points Higher To Extend Winning Streak to Seven Straight Sessions ...